LysoPE(16:0)
|
Basic information |
| Metabolite name | LysoPE(16:0) |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | LysoPE(16:0) |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | LysoPE(16:0) |
| N/A |
|
N/A |
|
N/A |
| Synonyms | LysoPE(16:0) |
| No. of studies | 10 |
|
Relationship between LysoPE(16:0) and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M061 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M096 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Up |
| Study M096 | Type1 | CUMS group vs. control group | Plasma | Wistar rat | Up |
| Study M096 | Type2 | CUMS + paroxetine group vs. CUMS group | Plasma | Wistar rat | Down |
| Study M1086 | Type1 | CUMS group vs. control group | Liver | C57BL/6 mouse | Up |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M123 | Type3 | rTMS group vs. control group | Striatum | Wistar rat | Up |
| Study M123 | Type3 | rTMS group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M124 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M125 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M454 | Type2 | vascular depression model + YXST group vs. vascular depression model group | Hippocampus | ICR mouse | Up |
| Study M512 | Type1 | CUMS group vs. control group | Plasma | Goto-Kakizaki rat | Down |
| Study M955 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M955 | Type2 | CUMS + deoiled and dechlorogenic acid-enriched sunflower seeds group vs. CUMS group | Hippocampus | C57BL/6J mouse | Up |
| Study M955 | Type2 | CUMS + deoiled sunflower seeds group vs. CUMS group | Hippocampus | C57BL/6J mouse | Up |